Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Immunoglobulin for CIDP
NCT01017159Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Apr 2010
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of subcuvia in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), sponsored by Aarhus University. Started Apr 2010; status: completed.
02
Drugs
subcuvia
03
Conditions
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Beyond the preview
Go deeper on NCT01017159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017159.